Clinical Trial

Stratifying Critically Ill Patients for Novel Ferroptosis or Pyroptosis Intervention Strategies

Study acronym: ICU-FERRO
Recruiting
View on ClinicalTrials.gov →
Summary
In order to better determine which therapy is best for patiënts which present with organ falure during the course of their stay in the intesive care unit (ICU) , one has to determine which underlying mechanism is causing this organ falure. We will determine levels of so called "biomarkers" for ferroptosis (a mechan ism of iron-related cell death) in the peripheral blood and biological fluids of criticaly ill patients admitted to the ICU with a catastrrophy (severe infection, trauma ...) . Why ? If it turns out that this ferroptosis plays a role in the ocurrence of organ failure in the critially ill, this will lead to new therapies in the future as drugs become more and more available which can influene this biochemical "pahway". of iron-relatd death.
Trial Details
NCT Number NCT06928649
Lead Sponsor University Hospital, Antwerp
Collaborators: Universiteit Antwerpen
Conditions Sepsis, Trauma Related Injuries, Subarachnoid Haemorrhage (SAH)
Enrollment 600 participants
Start Date 2024-03-13
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2025-04-15